TotalMarketCap

BlossomHill Therapeutics

BLSMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$549.561 M

$17.29 -13.29%

Close of 7 Oct 2026

As of 7 Oct 2026, BlossomHill Therapeutics (BLSM) has a market capitalization of $549.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

31,784,909

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #191CorMedixCRMD$567.4M
  2. #192CytomX TherapeuticsCTMX$557.8M
  3. #193BlossomHill TherapeuticsBLSM$549.6M
  4. #194Phathom PharmaceuticalsPHAT$548.5M
  5. #195Aclaris TherapeuticsACRS$544.6M

What if BlossomHill Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.8T

$905,757.96

Per share 52,386× higher

Bitcoin $1.67T

$52,548.45

Per share 3,039× higher

Nvidia $5.77T

$181,396.90

Per share 10,491× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for BlossomHill Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 8 Oct 2026. Read the methodology.